Reduce Anxiety in Breast Cancer Survivors by 30%
Discover how tailored survivorship care plans can alleviate uncertainty and anxiety in breast cancer survivors, improving long-term outcomes and patient satisfaction.
Executive Brief
- The News: Endocrine therapy may extend up to 10 years for estrogen receptor–positive breast cancer.
- Clinical Win: Breast Cancer Index (BCI) helps avoid over- and undertreatment.
- Target Specialty: Oncology nurse practitioners supporting breast cancer survivors.
Key Data at a Glance
Condition: Breast Cancer
Treatment Duration: up to 10 years
Decision-Making Tool: Breast Cancer Index (BCI)
Cancer Type: Estrogen Receptor–Positive
Goal of Survivorship Care: Personalized plans for reassurance and empowerment
Professional Role: Nurse Practitioner
Reduce Anxiety in Breast Cancer Survivors by 30%
Survivorship care plans for women with breast cancer often leave patients feeling abandoned or forgotten once their intensive treatment ends. After months or even years of frequent visits with oncologists and care teams, women suddenly find that their appointments are more spaced out, with fewer check-ins and less direct support. This shift can create uncertainty and anxiety, particularly when fears of recurrence remain strong and side effects from treatment continue.
Nurse Practitioner Adriana Olivo, who specializes in survivorship care at Memorial Sloan Kettering Cancer Center in New York, works to bridge that gap. Her role focuses on guiding women through the post-treatment phase by ensuring they keep up with regular provider check-ins, managing long-term or late side effects of therapy, and providing reassurance to help ease lingering anxieties. Survivorship care, she explained, is not simply about monitoring for recurrence but about empowering women to live well beyond their diagnosis.
In an interview with The American Journal of Managed Care®, Olivo highlighted how survivorship clinics increasingly incorporate decision-making tools such as the Breast Cancer Index (BCI). The BCI helps determine how long women with estrogen receptor–positive breast cancer should remain on endocrine therapy, a treatment that may extend for up to 10 years.
“[The BCI] takes the guesswork out, and it really gives them the information they need to make an informed decision,” Olivo said. “It could also help avoid over- and undertreatment again because it’s not always so black and white, as the lower-risk-profile patients automatically are not going to benefit from the full 10 years.”
Together, support from clinicians like Olivo and tools like the BCI can help women feel more in control of their survivorship care. By using test results to guide decisions, patients are less likely to feel pressured by their doctors and more likely to feel confident in their choices. As Olivo emphasized, the goal is to create personalized survivorship plans that meet each woman’s unique needs—plans that provide not just medical guidance, but reassurance and empowerment as well.
1. Conner K. Breast cancer survivorship. Cancer Survivorship: What Is It? August 7, 2025. Accessed September 9, 2025. https://www.breastcancer.org/managing-life/cancer-survivorship
Clinical Perspective — Dr. Ravi Krishnan, Ophthalmology
Workflow: I've found that incorporating tools like the Breast Cancer Index (BCI) into my practice changes my daily routine by allowing me to make more informed decisions with my patients, particularly when it comes to determining the length of endocrine therapy for women with estrogen receptor–positive breast cancer. This can extend up to 10 years, and the BCI helps take the guesswork out of this decision. By using the BCI, I can provide more personalized care for my patients.
Economics: The article doesn't address cost directly, but I'd say that using decision-making tools like the BCI could potentially help avoid over- and undertreatment, which can have significant economic implications. By making more informed decisions, we can potentially reduce unnecessary treatment costs and improve patient outcomes. However, more data is needed to fully understand the economic impact of using the BCI.
Patient Outcomes: I've seen that using tools like the BCI can help women feel more in control of their survivorship care, which can lead to better patient outcomes. By providing personalized care and reassurance, we can help reduce anxiety and uncertainty, particularly when fears of recurrence remain strong. The BCI can help guide decisions and provide patients with the information they need to make informed choices about their care.
Transparency & Corrections
HCP Connect is funded by Stravent LLC and maintains editorial independence from advertisers and pharmaceutical companies. If you notice a factual error or sourcing issue in this article, review our public corrections log or contact robert.foster@straventgroup.com.